… Class 3 human NAbs add to the anti-SARS-CoV-2 antibody repertoire and could probably
be effectively used in therapeutic combinations with class 1 or 2 NAbs. However, when using …

… selected in this study, the broad-spectrum neutralization activity of cocktail antibodies is the
Tri-combination, for which the only escape mutant was T478I. The T478I mutation accounted …

… We next studied the binding activity of these antibodies individually or in combination to the
spike protein of the three Omicron variants expressed on the surface of HEK293T (Figure 2). …

… Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and … and imdevimab) against
SARS-CoV-2 was approved for … against SARS--CoV-2 and its rapidly emerging variants. …

… COV2-2196 or COV2-2130 (with IC 50 of 15, 107 ng/mL to authentic virus, and 0.7, 1.6 ng/mL
to pseudovirus, respectively) alone or in combination protected mice from SARS-CoV-2 …

… In order to rank the individual antigens and combinations of antigens from SARS-CoV-2
for performance in discriminating the positive and negative groups, the receiver operating …

… -2 VOCs and demonstrated that the individual antibodies or their combination are
capable of potently neutralizing these emerging variants. Recent work from others has also …

… of coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV… , and their potential implications for SARS-CoV-2 infection. At …

… SARS CoV-2 is driven entirely by passive immunity with exogenous monoclonal antibodies
30 , … Our analyses are for a specific mAb combination and vaccine, similar analyses for other …

… perspectives either as a prophylactic agent in immunocompromised individuals with poor
response to vaccination or as combination therapy in SARS-CoV-2-infected individuals. …